| Natera, Inc. Common Stock | $32.0b | $258.49 | 0.0% | 2.6K | |
| Illumina Inc | $24.7b | $176.28 | 0.0% | 779 | |
| Labcorp Holdings Inc. | $21.3b | $267.86 | 0.0% | 13 | |
| QIAGEN N.V. | $7.5b | $38.73 | -0.3% | 1.5K | |
| BillionToOne, Inc. Class A Common Stock | $4.6b | $111.39 | 0.0% | 1.0K | |
| Veracyte, Inc. | $3.7b | $58.73 | 0.0% | 55 | |
| 10x Genomics, Inc. Class A Common Stock | $3.6b | $35.26 | 0.0% | 1.0K | |
| GeneDx Holdings Corp. Class A Common Stock | $1.5b | $68.42 | 0.0% | 816 | |
| NeoGenomics, Inc. | $1.4b | $13.64 | 0.0% | 7.5K | |
| Personalis, Inc. Common Stock | $1.2b | $12.35 | 0.0% | 6.0K | |
| CareDx, Inc. | $1.2b | $27.08 | 0.0% | 1.3K | |
| Opko Health Inc. | $1.1b | $1.51 | 0.0% | 7.2K | |
| Azenta, Inc. | $1.1b | $24.89 | 0.0% | 78 | |
| Mesa Laboratories Inc | $0.6b | $98.15 | 0.0% | 102 | |
| Fulgent Genetics, Inc. Common Stock | $0.5b | $19.45 | 0.0% | N/A | |
| Pacific Biosciences of California, Inc. | $462.8m | $1.57 | 0.0% | 16.9K | |
| Myriad Genetics Inc | $375.0m | $5.42 | 0.0% | 239 | |
| Prenetics Global Limited Class A Ordinary Share | $358.7m | $19.70 | 0.0% | N/A | |
| Insight Molecular Diagnostics Inc. Common Stock | $200.5m | $5.01 | 0.0% | 603 | |
| ALPS Group Inc Ordinary Share | $126.4m | $0.65 | 0.0% | N/A | |
| Quantum Cyber N.V. Ordinary Shares | $58.3m | $1.71 | +31.7% | 26.8M | |
| Bionano Genomics, Inc. Common Stock | $14.2m | $1.13 | 0.0% | 1.9K | |
| BioNexus Gene Lab Corp Common stock | $5.6m | $2.05 | 0.0% | 181 |